Windham Venture Partners is a New York City, New York based venture capital firm. They invest in healthcare companies, with an emphasis on medical technology and digital health.
When they invest, they look for a company to have an experienced and knowledgeable leadership team, an evidence-based technology or procedure which approaches a problem in a new or superior way without intellectual property barriers and a concept past development stage, addressing a large market with impressive data and a clear value proposition.
Investment
Windham Venture Partners has made investments in NovellusDx, MC10, Nebula Genomics, Earlens Corporation, Nuvaira, NeuSpera Medical, CVRx, CredSimple, SubjectWell, Science Exchange, Blueprint Health, Cartiva, Coravin and Cureatr.
Windham Venture Partners has exited investments in Transactis, Neotract and Cartiva.
Timeline
Funded Companies
Nebula GenomicsNebula Genomics is a genetics company developing a platform for individuals to get their personal genome sequenced, and then enable them to store and control that information through cryptographic encryption on the blockchain.
San Francisco
Simple HealthA technology company offering research and development services focused on cardiovascular disease.
California
Neuspera MedicalNeuspera Medical is a San Jose, California-based medical device company.
San Jose, California
Nuvaira, Inc.
Minneapolis
Personal Genome DiagnosticsPersonal Genome Diagnostics is a Baltimore-based company.
Baltimore
Earlens Corporation
IsraelPeople
Adam E. Fine
General Partner & CEO
Joseph Proto
Venture Partner
Lorne Taichman, MD, PhD
Director, Science & Technology
Luke Hartstein
Associate
Matthew Whitman
Principal
Raquel Babio
Operations Associate
Roger S. Fine
General Partner & Chairman
Further reading
Auto-extract from URL...
Documentaries, videos and podcasts
Auto-extract from URL...
Companies
Company
Venture capital
Biotechnology
New York City
Blueprint Health
Cartiva
Coravin
CredSimple
Cureatr
CVRx
